Voice-Controlled Medicament Pump for Remote Therapy Adjustment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current glucose control systems and ambulatory medical devices face challenges in maintaining uninterrupted therapy delivery, managing supply replenishment, and providing user-friendly control features, such as software updates, gesture-based controls, and remote modification capabilities, which are essential for effective glucose level management in subjects.
Innovation Solution
The implementation of interconnected remote computing systems, mobile devices, and medicament delivery devices that enable software updates without interrupting therapy, gesture-based control, automatic resumption of therapy, improved alarm management, wide area network connectivity, security features, and voice/verbal command modifications, along with autonomous dosing recommendations and supply monitoring and ordering.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If software updates are implemented in the ambulatory medicament pump, then system functionality and security are improved, but therapy delivery may be interrupted
Solution Approach 1:
The system performs preliminary actions by downloading and storing update files in memory before therapy delivery needs to be maintained. The controller prepares the update environment in advance, including allocating memory space and verifying file integrity, so that the actual update can be applied without interrupting ongoing therapy delivery to the subject.
Solution Approach 2:
The update process is segmented into distinct phases: download phase, verification phase, and installation phase. During the download and verification phases, therapy delivery continues uninterrupted. The installation phase is scheduled for appropriate times when therapy can be temporarily paused, thus segmenting the update process to minimize disruption to continuous therapy delivery.
2Ease of operation
If voice command interface is added to the pump, then ease of operation is improved, but device complexity increases
Solution Approach 1:
A voice processing module serves as an intermediary between the user's voice commands and the pump's control system. This module captures voice input, processes it through speech recognition algorithms, and translates it into standardized control signals that the existing pump controller can execute, thereby adding voice control capability without requiring fundamental changes to the core pump architecture.
Solution Approach 2:
The voice command interface is designed to handle multiple functions through a single unified system. The same voice processing module can recognize and execute various types of commands including therapy adjustments, supply monitoring requests, and system status inquiries, making the added complexity serve multiple purposes rather than requiring separate systems for each function.
3Ease of operation
If supply monitoring and automatic ordering system is implemented, then ease of operation is improved, but device complexity and cost increase
Solution Approach 1:
The system implements self-service functionality by automatically monitoring supply levels through sensors integrated with the pump mechanism. When supplies fall below predetermined thresholds, the system automatically generates and transmits reorder requests to healthcare providers or supply distributors, eliminating the need for manual monitoring and ordering by the user while maintaining simple operation.
Data Source
AI summary
Ambulatory medical devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can transmit a request to modify blood glucose control therapy delivered to a subject. The request can be transmitted via a voice-activated control system, the ambulatory medicament pump can include a medicament reservoir, a pump controller, a wireless data interface, and/or other elements. The device can receive an indication that the request to modify therapy is approved and, in response to the indication that the request to modify the blood glucose control therapy is approved, instruct the pump controller to modify the blood glucose control therapy delivered to the subject.


